Jeff Jonas is the founder of SAGE Therapeutics. SAGE Therapeutics has raised $93M in total funding. Latest round: Series C. Based in Boston, United States.
Jeff Jonas is a biotech veteran who previously served as CEO of SAGE Therapeutics. He is recognized for his leadership at SAGE Therapeutics during its growth phase, including through Series C funding. He is now the CEO of Abio-X, a biotech incubator in the Boston area.
Full founder directory · Investor directory · Company funding database · Fundraising library